Effects of talking about side effects versus not talking about side effects on the therapeutic alliance: A controlled clinical trial
Acta Psychiatrica Scandinavica · 2023
DOI: 10.1111/acps.13543 ↗Kurz gefasst
Kontrollierte klinische Studie in der Zeitschrift Acta Psychiatrica Scandinavica, 2023. Verfasst von Beate Muschalla und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychotherapy and Diagnostics, Technische Universität Braunschweig, Braunschweig, Germany. Hauptthemen laut MEDLINE: Therapeutic Alliance. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Side effects of psychotherapy are common. Therapists and patients must recognize negative developments to take countermeasure. Therapists can be reluctant to talk about problems of their own treatment. The hypothesis could be that talking about side effects can impair the therapeutic relationship.
Methods
We examined whether a systematic monitoring and discussion of side effects has a negative effect on therapeutic alliance. Intervention group (IG) therapists and patients filled in the UE‐PT scale (unwanted events in the view of patient and therapists scale) and discussed their mutual ratings (IG, n = 20). As unwanted events can be independent of therapy, but also be treatment‐related side effects, the UE‐PT‐scale first asks for UE and then for their relation to the ongoing treatment. In the control group (CG, n = 16) treatment was done without any special side effect monitoring. Both groups filled in the Scale for Therapeutic Alliance (STA‐R).
Results
IG‐therapists reported various unwanted events in 100% and patients in 85% of cases: complexity of problems, burdensome or overdemanding therapy, problems with work, and symptom deterioration. Any side effect was reported in 90% by therapists and in 65% by patients. Most frequent side effects were demoralization and worsening of symptoms. IG therapists observed an improvement of global therapeutic alliance in STA‐R (M = 3.08 to M = 3.31, p = 0.024, interaction effect in ANOVA with two groups and measurement repetition), and reduced patient fear (M = 1.21 to M = 0.91, p = 0.012). IG patients perceived improvement in bond (M = 3.45 to M = 3.70, p = 0.045). In the CG no comparable changes were seen (alliance M = 2.97 to M = 3.00; patient fear M = 1.20 to M = 1.36; patient‐perceived bond M = 3.41 to M = 3.36).
Conclusion
The initial hypothesis must be rejected. The results suggest that monitoring, and discussion of side effects can even improve the therapeutic alliance. Therapists must not be afraid that this will endanger the therapeutic process. The use of a standardized instrument like the UE‐PT‐scale seems helpful.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychotherapy and Diagnostics, Technische Universität Braunschweig, Braunschweig, Germany.
- Department of Psychosomatic Medicine, Charité University Medicine Berlin, Berlin, Germany.
ORCID-Profile: Beate Muschalla
Zitieren
APA
Muschalla, B., Müller, J., Grocholewski, A., & Linden, M. (2023). Effects of talking about side effects versus not talking about side effects on the therapeutic alliance: A controlled clinical trial. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13543
Vancouver
Muschalla B, Müller J, Grocholewski A, Linden M. Effects of talking about side effects versus not talking about side effects on the therapeutic alliance: A controlled clinical trial. Acta Psychiatrica Scandinavica. 2023. doi:10.1111/acps.13543
BibTeX
@article{Muschalla2023,
author = {Muschalla, Beate and Müller, Julia and Grocholewski, Anja and Linden, Michael},
title = {Effects of talking about side effects versus not talking about side effects on the therapeutic alliance: A controlled clinical trial},
journal = {Acta Psychiatrica Scandinavica},
year = {2023},
doi = {10.1111/acps.13543}
}
EUVIMED